Table 1 Clinical characteristics of patients with BRVO-induced ME
From: Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
characteristic | Major BRVO | Macular BRVO | t, χ2 | P |
|---|---|---|---|---|
(n = 22) | (n = 14) | |||
Male | 10 (50.0%) | 6 (42.9%) | 0.02 | 0.88 |
Female | 12 (50.0%) | 8 (57.1%) | ||
Age (years) | 64.35 ± 8.30 | 66.19 ± 8.06 | 0.66 | 0.52 |
Onset Time (months) | 4.60 ± 2.20 | 5.00 ± 2.10 | 0.54 | 0.59 |